News Releases

2009

XXX
Dec.11,2009
Launch of a Type 2 Oral Antidiabetic Drug, GLACTIV® Tablet (19.7KB)
XXX
Dec.11,2009
Launch of Antiemetic Drug, EMEND® Capsule (18.1KB)
XXX
Oct.16,2009
Approval Received for a Type 2 Oral Antidiabetic Drug Glactiv® Tablet (17.0KB)
XXX
Oct.16,2009
Approval Received for Antiemetic Drug EMEND® Capsule (16.8KB)
XXX
Oct.15,2009
Ono Signs New Drug Discovery Agreement with Evotec AG Targeting an Ion Channel (15.1KB)
XXX
Sep.02,2009
License Agreement of a Drug Candidate for Irritable Bowel Syndrome with Tioga (8.6KB)
XXX
Jun.02,2009
Data from ongoing Phase 1 expansion cohort and Multi-Dose Phase 1b Trials of Investigational Fully Human Anti-PD-1 Antibody “ONO-4538/MDX-1106” in Cancer Patients at American Society of Clinical Oncology Annual Meeting (32.4KB)
XXX
May.13,2009
Partial Revisions to the Articles of Incorporation (178KB)
XXX
May.13,2009
Announcement on Changes of Representative Directors and Members of the Board of Directors (178KB)
XXX
Apr.06,2009
Launch of the Osteoporosis Treatment, RECALBON® Tablets / Bonoteo® Tablets (16.4KB)
XXX
Mar.12,2009
Ono Enters into Drug Discovery Agreement on Ion Channel Targets with Xention (12.9KB)
XXX
Jan.21.2009
Ono Approval for the Osteoporosis Treatment, RECALBON® Tablets / Bonoteo® Tablets (13.6KB)